The NLRP3 activation-related signature predicts the diagnosis and indicates immune characteristics in endometriosis

Other OA: closed CC-BY-4.0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-14 ⓘ

This study identified four diagnostic markers (NLRP3, IL-1β, LY96, and PDIA3) related to NLRP3 activation for endometriosis and suggested niclosamide as a potential therapeutic agent.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-12 · read from full text ⓘ

This study utilized gene expression datasets from the Gene Expression Omnibus to identify four key diagnostic markers for endometriosis associated with NLRP3 inflammasome activation: NLRP3, IL-1β, LY96, and PDIA3. The researchers employed machine learning algorithms to construct a diagnostic model that demonstrated strong predictive performance, which was subsequently validated through western blotting of patient tissue samples and additional independent datasets. Furthermore, the analysis explored immune cell infiltration patterns and identified niclosamide as a potential therapeutic agent targeting these biomarkers. This paper is centrally about endometriosis — specifically focusing on the development of a molecular diagnostic signature based on NLRP3-related genes to improve disease detection and understanding of its inflammatory mechanisms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis (EMS) is a prevalent gynecological disease that leads to chronic pelvic pain and infertility in women of reproductive age. However, the underlying pathogenic genes and effective treatment for EMS remain unclear. Therefore, this study aims to identify key genes influencing the diagnosis and treatment of EMS. The GSE7307 dataset, comprising 18 EMS and 23 control samples, was obtained from the GEO database. Fourteen differential genes related to NOD-like receptor protein 3 (NLRP3) activation and EMS were extracted from endometrial samples in GSE7307 through differential analysis. GO and KEGG analyses revealed that these genes were primarily involved in the production and regulation of the cytokine IL-1β and the NOD-like receptor signaling pathway. Random Forest (RF) and support vector machine recursive feature elimination algorithms were employed to select four diagnostic markers related to NLRP3 activation (NLRP3, IL-1β, LY96, and PDIA3) for constructing the EMS diagnostic model. These markers were validated using western blotting and tested in GSE7305 and GSE23339 datasets. The AUC values demonstrated the model's robust diagnostic performance. Additionally, the infiltration of immune cells in the samples and the correlation between different immune factors and diagnostic markers were explored. These results suggest that the four diagnostic markers may also play a crucial role in EMS immunity. Finally, the DrugBank database indicated that niclosamide could be effective for NLRP3-targeted therapy. In conclusion, we identified four key diagnostic genes for EMS, and niclosamide emerged as a potential drug for NLRP3-targeted therapy in EMS.
Full text 47,500 characters · extracted from oa-pdf · 10 sections · click to expand

Keywords

Endometriosis, GEO, Diagnostic marker, Nomogram, Immune cells inltration Posted Date: May 3rd, 2023 DOI: https://doi.org/10.21203/rs.3.rs-2830815/v1 Page 2/28 License:   This work is licensed under a Creative Commons Attribution 4.0 International License.   Read Full License Page 3/28

Abstract

Endometriosis (EMS) is a common gynecological disease leading to chronic pelvic pain and infertility in women of reproductive age, but its underlying pathogenic genes and effective treatment are still unclear. To date, abnormal expression of NLRP3 activation-related genes has been identied in EMS patients and mouse models. Therefore, this study sought to identify the key genes that could affect the diagnosis and treatment of EMS. The GSE7307 dataset was downloaded from the Gene Expression Omnibus (GEO) database, including 18 EMS samples and 23 control samples. 14 differential genes related to NLRP3 activation and EMS were obtained from the endometrial samples of GSE7307 by differential analysis. GO and KEGG analysis showed that these genes were mainly involved in the production and regulation of the cytokine IL-1 β , and the NOD-like receptor signaling pathway. Random Forest (RF) and support vector machine recursive feature elimination (SVM-RFE) algorithms were used to select four diagnostic markers related to NLRP3 activation (NLRP3, IL-1 β , LY96 and PDIA3) to construct the EMS diagnostic model. The four diagnostic markers were veried using western blotting and validated in the GSE7305 and GSE23339 datasets. The AUC values showed that the model had a good diagnostic performance. In addition, the inltration of immune cells in the samples and the correlation between different immune factors and diagnostic markers were further discussed. These results suggest that four diagnostic markers may also play an important role in the immunity of EMS. Finally, 10 drugs targeting to four diagnostic markers were retrieved from the DrugBank database, of which niclosamide proved useful for treating EMS. Overall, we identied four key diagnostic genes for EMS. In addition, large-scale and multicenter prospective cohort studies are necessary to conrm whether these four genes also have valid diagnostic value in blood samples from EMS patients.

Introduction

Endometriosis (EMS) is a chronic inammatory disease dened as the presence of endometrial tissue outside the uterus, causing pelvic pain and infertility, affecting 5–10% of women of reproductive age worldwide[1, 2]. The most prevalent theory of the origin of endometriosis, advanced by Sampson (1928), holds that during menstruation, endometrial cells and tissue fragments return through the fallopian tubes, survive, attach and invade pelvic structures[3]. Depending on the location of the disease, EMS is classied as supercial (or peritoneal), ovarian (endometrioma), and deep (dened as invasive lesions greater than 5 mm in depth). The diagnosis of EMS is made primarily through laparoscopy, based on an empirically guided clinical decision based on history, symptoms, clinical examination, and imaging, whereas biochemical markers lack sensitivity and specicity[4, 5]. Therefore, it is necessary to explore the underlying molecular mechanism and nd new markers to provide more meaningful and reliable diagnostic information for EMS treatment, so as to promote early diagnosis and individualized treatment. Nod-like receptor protein 3 (NLRP3) is a component of the inammasome that activates caspase1, promoting the processing of IL-1 β and IL-18 into biologically active mature forms and inducing pyroptosis[6, 7]. Furthermore, NLRP3 inammasome-mediated pyroptosis has been reported to play a crucial role in the pathogenesis of inammatory diseases[8, 9]. EMS is also a chronic inammatory Page 4/28 disease, and previous studies have also reported an association between NLRP3 inammasome and the progression of EMS[10, 11]. A study has reported that targeted inhibition of NLRP3 can inhibit the production of IL-1 β and cell proliferation in EMS, thereby improving ovarian function in EMS[12]. Estrogen receptor(ER) β has been reported to interact with components of the inammasome in endometriotic cells, increasing interleukin-1 β to enhance their cell adhesion and proliferative properties, thereby increasing the invasive activity of endometrial tissues to establish ectopic lesions[13]. Due to the non-negligible relationship between NLRP3 activation and EMS, it is necessary to explore the specic role of NLRP3 activation-related features in EMS and identify more diagnostic biomarkers. In this study, we conducted a systematic study of NLRP3 activation-related genes to explore the differential expression of these genes in EMS patients and normal controls and to construct an effective diagnostic nomogram model for clinical application. Inammation is a vital pathological feature of EMS, which is closely related to immune function. Therefore, we further explored the immune penetration of these samples and the correlation between different immune factors and these diagnostic biomarker candidates. In addition, ten drugs targeting these diagnostic biomarker candidates were retrieved from the DSigDB database, which has implications for the pharmacotherapy of EMS. Therefore, this study provides potential targets for the diagnosis and treatment of EMS. The workow of this study is shown in Fig. 1.

Materials and methods

Data acquisition First, the three datasets, GSE7307 (including 18 EMS samples and 23 normal samples) ,  GSE7305 (including 10 EMS samples and 10 normal samples), and GSE23339 (including 10 EMS samples and 9 normal samples ) were downloaded from Gene Expression Omnibus (GEO) database. The data processing steps are as follows: (1) match multiple probes to the same gene, (2) remove the null probes, (3) rst match probes to genes, and (4) log2 transformation of the obtained data set. The number of bits used to normalize signal strength. DEGs in EMS Gene expression difference data between EMS samples and normal samples were examined by using a limma package in R and using a threshold with a modied P value of 0.05 or less. Functional enrichment analysis of the DEGs To explore the biological mechanism of differentially expressed genes (DEGs) affecting EMS, a functional enrichment analysis was carried out. First, the “clusterProler” and “ggplot2” packages were employed for Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) was used Page 5/28 for enrichment analyses of DEGs[14]. Adjusted P < 0.05 had signicance in statistics. Subsequently, Gene Set Enrichment Analysis (GSEA) that used the ‘Clusterproler’ R package to perform revealed the respective function of each key gene. The samples were divided into low-expression groups and high- expression groups according to median values of the expression levels in key genes. The genes were sorted from highest to lowest by logFC, and the rst 5 and last 5 GSEA results were taken after sorting. These gene sets were downloaded from the Molecular Signature Database (MSigDB, https://www.gsea- msigdb.org/gsea/msigdb/ index.jsp). The nal result is displayed in the "enrichplot" package of the R software. P-values < 0.05 was considered to be statistically signicant. Screening for candidate diagnostic biomarkers Diagnostic markers of EMS were classied using random forest (RF) and support vector machine recursive feature elimination (SVM-RFE) arithmetic methods. The  RF algorithm randomizes a single decision tree overtting reduction algorithm and improves model accuracy based on many related decision trees in the training set[15]. SVM-RFE as a support vector monitoring machine learning method identies optimal variables via the deletion of the SVM-produced eigenvectors[16]. Markers selected for EMS diagnosis were classied and analyzed using the SVM classier in the R package e1071. Verication of the diagnostic biomarker results Endometrium from endometriosis patients or matched control patients came from the Aliated Hospital of Youjiang Medical College for Nationalities, Baise, China. We collected 12 cases diagnosed as ovarian endometriosis cysts (n=6) and non-endometriosis (n=6) with inclusion conditions: ageg between 26 and 46 years, BMI of 21-27 kg/m2, non-vegetarian patients, no contraindications for surgery; The exclusion criteria were endocrine diseases such as diabetes, and severe gastrointestinal, heart, lung, and liver diseases. All the donors did not take drugs and hormones before surgery, and underwent combined uterine and abdominal surgery at the same time due to abnormal uterine bleeding. All tissue samples were obtained from tissue resected during surgery and were approved and informed by the patient and the ethics review committee of our hospital. Protein preparation and western blotting were performed as described previously[17]. Endometrial tissue lysates (500 μ L in RIPA lysis buffer  PMSF= 94:6) were processed for western blotting, where protein concentrations were determined with BCA Protein Assay Kit. Then, proteins were denatured by boiling at 100 °C for 10 min. SDS-PAGE was conducted with denatured protein samples of approximately 20 μ g loaded onto a 10% Tris–acetate gel, run at 120 V for 2 h. Proteins in the gel were transferred onto polyvinylidene uoride membranes at 300 mA for 50 min, and blocked in PBST containing 5% skim milk powder for 2 h. After washing with PBST, the membranes were respectively incubated with antibodies against NLRP3 (1:1000 dilution, bs-10021R; Bioss, Beijing, China), LY96 (1:1000 dilution, 11784-1-AP; proteintech, Wuhan, China), IL-1 β  (1:3000 dilution, 26048-1- AP; proteintech), PDIA3 (1:8000 dilution, 15967-1-AP; proteintech), and TUBULIN (1:20000 dilution, 66031- 1-Ig; proteintech) overnight at 4 °C, and washed with PBST three times for 10  min each. It was then incubated for 2 h at room temperature with a goat anti-rabbit IgG (1:5000 dilution, SA00001- Page 6/28 2; proteintech) and a goat anti-mouse IgG (1:5000 dilution, SA00001-1; proteintech) horseradish peroxidase (HRP)-conjugated secondary antibody. After three 10-min washes of the membrane in PBST, eECL was added, and the Tanon-5500 Chemiluminescence Imaging System was used to detect the chemiluminescence of protein bands.  Diagnostic value of the key genes in EMS The generalized linear model (GLM), support vector machine model (SVM), extreme gradient boosting model (XGB), and random forest model (RF) were performed based on the combined training dataset. The four models were analyzed using the interpretation function of DALEX package in R, and the residual distribution was performed to obtain the optimal model. We constructed ROC curves to examine the predictive utility of the proposed biomarkers by using mRNA expression data from 23 normal samples and 18 EMS samples. EMS and control samples were separated by ROC analysis and further validated in GSE7305 and GSE23339 datasets. Distribution of the immune cells The CIBERSORT (http://cibersortx.stanford.edu) algorithm was used to calculate the relative proportions of the 22 immune cell types in the training dataset samples. Analysis of genes identied and immune cells inltrated Spearman rank correlation analysis was used to determine the correlation between the four key diagnostic genes and the number of inltrating immune cells. The graph method of the ggplot2 package is used to show the correlation of results. Construction of nomogram and diagnostic score model First, a nomogram model for predicting the occurrence of EMS was constructed using the rms package (version 5.1-2)[18]. Then, the calibration curve was constructed to assess the diagnostic power of the nomogram model. Finally, the clinical value of the nomogram model was evaluated by using decision curve analysis (DCA). Prediction of potential drug compounds The Drug Signature Database (DSigDB) was used to screen potential drug molecules with gene-based interactions. As a public web-based database derived from an enrichment web server, DSigDB provides information about drugs and their target genes for GSEA[19]. Based on a statistical threshold of adjusted Page 7/28 p-value < 0.05, we identied protein-drug interactions in the EMS-pyroptosis interaction that may affect important central genes. Statistical analysis. All analyses were performed in R program 4.0.2. The t-test and the Mann-Whitney U-test were chosen based on whether the data t a normal distribution. The Spearman correlation method was used to study the relationship between the expressions of diagnostic genes and inltration immunocytes. P values < 0.05 was considered statistically signicant.

Results

Determination of DEGs in EMS To investigate DEGs of EMS, we examined the GSE7307 dataset and identied 14 DEGs in EMS, including 11 up-regulated genes (CASP1, IL10, IL17RA, IL1B, IL1R1, IL6, LY96, NLRP3, P2RX7, PIK3CA and TLR4) and 3 down-regulated genes (EIF2AK3, HMGB1 and PDIA3) (Fig. 2A and 2B). Enrichment analysis of biological process and pathway GO analysis results showed that DEGs were mainly rich in positive regulation of cytokine production, cellular response to biotic stimulus, cellular response to lipopolysaccharide, cellular response to molecule of bacterial origin, response to lipopolysaccharide, interleukin-1 production, regulation of interleukin-1 production, positive regulation of interleukin-1 beta production, positive regulation of interleukin-1 production, and regulation of cytokine production involved in the immune response (Fig. 3A). KEGG assays revealed that DEGs were mainly enriched in the NOD-like receptor signaling pathway (Fig. 3B).  Detection and verication of diagnostic genes in EMS Two machine learning methods were applied in selecting potential markers of EMS: SVM-RFE and RF. We rst screened 14 DEGs with SVM-RFE analysis and identied 10 diagnostic biomarkers (Fig. 4A). RF analysis identied 4 diagnostic biomarkers from 14 DEGs (Fig. 4B and 4C). After integrating the characteristic genes from SVM-RFE and RF, four characteristic genes closely related to pyroptosis were obtained: NLRP3, IL-1 β , LY96, and PDIA3 (Fig. 4D). The expression of NLRP3, IL-1 Β , and LY96 was distinctly upregulated in EMS, and the expression of PDIA3 was distinctly upregulated in EMS (Fig. 5A). The diagnostic value of four overlapping genes was shown by the use of ROC assays (Fig. 5B). We veried the results of the screened differential genes at the protein level. The verication results revealed that the protein (Fig. 6A and 6B) levels of NLRP3 (P<0.05), LY96 (P<0.01) and IL-1 β (P0.05) were the opposite, consistent Page 8/28 with the Gene Chip data with multiple exposures. Moreover, we further determined the diagnostic value of NLRP3, IL-1 β , LY96 and PDIA3 in the GSE7305 and GSE23339 datasets, and the results are shown in Fig. 7. We established the RF, SVM, XGB, and GLM models to choose NLRP3 activation-related genes to predict the incidence of EMS. Both “Reverse Cumulative Distribution of Residual” (Fig. 8A) and “Boxplots of Residual” (Fig. 8B) indicate that the GLM model has minimal residuals. The ROC curve was drawn to evaluate the model, and the AUC value of the ROC curve also indicated that the GLM model had higher accuracy compared with the other three models (Fig. 8C). Finally, the ROC curve also demonstrated the good diagnostic performance of the four genetic biomarker combinations based on the four classication models in both validation datasets (GSE7305 and GSE23339) for normal women and EMS patients. (Fig. 8D and 8E). Analysis of functional correlations Gene set enrichment analysis (GSEA) was performed for the four key genes based on the median expression prole. GSEA expression analysis of four genes in NLRP3 showed that the gene expressions of malaria, pertussis, systemic lupus erythematosus immune-related diseases and biological processes of complement and coagulation cascades and taurine and hypotaurine metabolism were signicantly increased in the high expression group, while base excision repair, DNA replication, Fanconi anemia pathway, homologous recombination, and mismatch repair in the low expression group (Fig. 9A). The IL- 1 β in the high expression group were signicantly enriched in the legionellosis, malaria, systemic lupus erythematosus, complement and coagulation cascades, and viral protein interaction with cytokine and cytokine receptor, whereas those in the low-expression groups were signicantly enriched in aminoacyl−tRNA biosynthesis, base excision repair, DNA replication, homologous recombination, and mismatch repair (Fig. 9B). The LY96 in the high-expression group was signicantly enriched in asthma, legionellosis, malaria, systemic lupus erythematosus, and complement and coagulation cascades. On the other hand, LY96 in the low expression groups was signicantly enriched in base excision repair, DNA replication, Fanconi anemia pathway, homologous recombination, and mismatch repair (Fig. 9C). Ultimately, the PDIA3 in the high expression group was signicantly enriched in DNA replication, Fanconi anemia pathway, homologous recombination, mismatch repair, and protein export, nevertheless, those in the low expression group were signicantly enriched in asthma, malaria, pertussis, systemic lupus erythematosus, and taurine and hypotaurine metabolism (Fig. 9D). Correlation between four diagnostic genes and EMS immune permeation level In this study, the proportion of 21 immune cells in 18 EMS samples and 23 Normal samples was estimated with the CIBERSORT algorithm, which can be seen in the histograms. The abundance of B cells memory, Plasma cells, T cells CD4 memory resting, Macrophages M2, Mast cells activated, and Eosinophils were higher in EMS samples than that in normal samples, while the inltration abundance of Page 9/28 B cells naïve, NK cells activated, and Mast cells resting in EMS samples were lower (Fig. 10A and 10B). Four biomarkers (NLRP3, IL-1 β , LY96 and PDIA3) were associated with 6 signicantly different immune cells in 21 immune cell types, including Dendritic cells activated, Dendritic cells resting, Eosinophils, Macrophages M1, Monocytes, and Plasma cells (Fig. 10C and 10D). As shown in Figure 9D, NLRP3 was negatively correlated with B cells naïve only. IL-1 β was positively correlated with Plasma cells but negatively correlated with Mast cells resting and T cells CD4 naïve. LY96 was related to Plasma cells, Macrophages M2, B cells mEMSory, T cells gamma delta, and Eosinophils in a positive way, while negatively related with B cells naïve, NK cells activated, Dendritic cells activated, Mast cells resting, T cells CD8, and T cells follicular helper. PDIA3 has positively correlated with T cells CD4 memory activated when negatively correlated with B cells memory and Macrophages M2.   Construction and assessment of the diagnostic nomogram model A nomogram was created to validate the diagnostic power of the four EMS biomarkers (Fig. 11A). The calibration curve showed a small error between the actual EMS risk and the predicted risk, indicating that the nomogram model had a high accuracy in predicting EMS (Fig. 11B). DCA showed that the nomogram curve was higher than the gray critical line and the four biomarker curves, indicating that the nomogram model had the best clinical benet (Fig. 11C).  Identication of candidate pharmacologic agents Four well-validated diagnostic genes (NLRP3, IL-1 β , LY96, and PDIA3) were used as genetically linked targets to facilitate further studies in therapeutic development by a drug target enrichment analysis was performed (Table 1). We have listed the top 10 candidate enrichment agents targeting gene links, which may be targeted for the development of co-onset therapeutic strategies. Studies have shown that niclosamide can target and inhibit macrophage-induced endometriosis inammatory microenvironment, thereby improving reproductive function[20–22]. In addition, our analysis of the results based on Table 1 indicates that niclosamide is considered a candidate molecule for the treatment of EMS because of its high odds ratio and high composite score.

Discussion

Endometriosis, a gynecological disease characterized by the implantation of endometrial tissue outside the uterus, has attracted increasing attention worldwide recently. However, despite its prevalence, diagnosis is often delayed by years, misdiagnosis is common, clinical presentations are varied, and the presence of pelvic lesions is heterogeneous[1]. Currently, EMS is usually treated with a combination of hormone therapy and surgery to remove the lesion[23]. Despite recent advances in the medical treatment of endometriosis-related pelvic pain, there are still no drugs available to treat the condition[24]. Therefore, Page 10/28 the identication of novel molecular factors and the unraveling of the underlying mechanisms of EMS will facilitate early diagnosis and the development of effective therapies. In the present study, we identied DEGs across the GSE7307 dataset including 18 EMS samples and 23 normal samples. These DEGs included 11 upregulated and 3 downregulated genes, respectively. GO and KEGG analyses revealed that these DEGs were involved in regulating immune-related signaling pathways, such as the production and regulation of the cytokine IL-1 β , as well as the NOD-like receptor signaling pathway. We applied the machine learning methods of SVM-RFE and RF to integrate the feature genes and obtained four feature genes: NLRP3, IL-1 β , LY96 and PDIA3. Then, we further conrmed their diagnostic using GSE7305 and GSE23339 datasets, and further demonstrated NLRP3, IL-1 β , LY96 and PDIA3 as critical biomarkers for EMS based on the results of ROC assays. The inammasome is newly discovered and plays an important role in innate immunity. The most typical is the NLRP3 inammasome, the so-called NLRP3 protein because the NLRP3 protein in this complex belongs to the family of nucleotide-binding and oligomerization domain-like receptors (NLRs), also known as "pyrin domain-containing protein 3"[25]. The expression of NLRP3 in EMS tissues and serum of EMS patients was higher than that of normal controls, which contributed to the invasion of EMS[26]. Since EMS is a gynecologic disorder associated with estrogen, higher estrogen receptor (ER)- β levels and enhanced ER- β activity are detected in endometriotic tissues. ER- β is known to interact with NALP3, and the activation of NALP3 increases interleukin IL-1 β and IL-18, thereby enhancing cell adhesion and proliferation[27]. The NLRP3 inhibitor (MCC950) has recently been reported to signicantly reduce the co- localization of NLRP3 and IL-1 β in cyst-derived stromal cells (CSCs) and IL-1 β concentration in the supernatant of CSCs. Thereby contributing to Ovarian endometriosis (OE) suppression and improving ovarian function in endometriosis[12]. However, the specic mechanism of NLRP3 in EMS is still unclear. IL-1 β plays a considerable role in inammatory diseases and the main sources of its secretion are macrophages and monocytes, dendritic cells (DC), B lymphocytes, neutrophils and natural killer (NK) cells and non-immune cells such as keratinocytes[28]. The maturation of IL-1 β and IL-18 induces pyroptosis, a form of cell death[29]. The inammatory factor IL-1 β has been reported to be signicantly increased in ectopic endometrial tissue of patients with EMS[30], which is consistent with our results. Chronic pelvic pain is one of the main clinical symptoms of female endometriosis, but its specic mechanism is unclear. IL-1 β is closely related to inammatory pain by sending inammatory pain signals to the hypothalamus and participating in afferent pain response[31]. A retrospective study of peritoneal uid samples obtained by laparoscopy found an increase in IL-1 β concentration compared with normal controls that were statistically signicant only in women with endometriosis who reported pelvic pain[32]. In addition, some studies have revealed the mechanism of deep dyspareunia in endometriosis, that is, IL-1 β stimulates the expression of nerve growth factor (NGF), promotes local neurogenesis around endometriosis, and then leads to tenderness in the pelvic anatomy, leading to deep dyspareunia[33]. Because IL-1 β can induce NGF expression and increase NGF bioactivity, dienogest, a selective P-receptor (PR) agonist, Inhibition of NGF expression by PR-A and PR-B in human endometrial epithelial cells (hEECs) may contribute to the relief of endometriosis pain[34]. Sulforaphane alleviates pain caused by sciatic nerve endometriosis, Page 11/28 which is mediated by the inhibition of inammatory cytokines IL6, IL-1 β , and TNF- α [35]. Overall, pharmacological targeting of IL-1 β /NGF may also have the potential for the treatment of endometriosis- related pain. LY96 plays a crucial role in inammation-related and immune-related diseases, such as Crohn's disease, rheumatoid arthritis, and inammatory diabetic cardiomyopathy[36]. Key protein disulde isomerase 3 (PDIA3) is a kind of chaperone, that can adjust the folding of the new synthesis glycoprotein, the heterogeneous and REDOX enzyme activity, and immune activation marks, cancer immune cells and immune modulators signicantly related, is a powerful cancer prognosis biomarkers, which can effectively predict the immune response to treatment[37, 38]. Similarly, the expression and function of LY96 and PDIA3 in EMS remain are largely unknown. Furthermore, we also evaluated the degree of inltration of 22 immune cells in EMS and normal samples. Compared with normal samples, EMS samples had distinctly higher levels of B cells memory, Plasma cells, T cells CD4 memory resting, Macrophages M2, Mast cells activated, and Eosinophils. It is well known that endometriosis lesions are characterized by the presence of numerous plasma cells and activated macrophages[39]. One study found that the relative abundance of resting CD4 + memory T cells and even less abundant memory B cells were signicantly higher in patients with stage III/IV endometriosis, which was strongly associated with endometrial receptivity[40]. Activated macrophages are generally divided into two groups, M1-like macrophages and M2-like macrophages, both of which are closely related to the inammatory response[41]. Another study found a signicant increase in total macrophages in ectopic endometrial tissue (EC) and a syngeneic mouse model of endometriosis, and M2 macrophages were the predominant macrophages in EC[42, 43]. Of note, M2 macrophages have been found to increase gradually from stage I to stage IV in ectopic endometrial tissues of EMS patients, whereas M1 macrophages have been found to increase in contrast, which may contribute to the proinammatory microenvironment in the early stage of the disease, as well as to the probrotic activity in the late stage[44]. Diffuse inltration of large numbers of mast cells (MCs) is observed in the interstitium of ectopic endometrial tissues of EMS. MCs promote the development of endometriosis through NLRP3 inammasome activation mediated by nuclear-initiated estrogen signaling pathway and the production of mature IL-1 β [45, 46]. In addition, the preoperative pain score of EMS is closely related to the density and number of mast cells, and the use of MCs stabilizers and inhibitors can relieve endometriosis and its associated pain[47, 48]. Eosinophils can regulate broblasts and stimulate collagen synthesis. Eosinophils are abundant in brotic areas and peritoneal uid of endometriosis, which is associated with brosis of endometriosis lesions[49, 50]. Moreover, we found that the expressions of NLRP3, IL-1 β , LY96, and PDIA3 were related to the levels of many immune cells, highlighting their potential used as therapeutic targets for EMS. Hence, The differential expression of NLRP3, IL-1 β , LY96, and PDIA3 between EMS and normal groups pointed out they might be crucial immune-related biomarkers to diagnose EMS. A diagnostic nomogram model based on four core genes with excellent predictive power was established, and patients would benet from this model. Page 12/28 Finally, based on four diagnostic genes as gene junction points, we identied niclosamide as a candidate molecule for EMS treatment due to its high odds ratio and high comprehensive score among the top 10 candidate enrichment agents by drug target enrichment analysis. Niclosamide was discovered in 1953 at the Bayer Chemotherapy Research Laboratory to treat tapeworm infections in humans and is listed on the World Health Organization's Essential Medicines List[51]. However, accumulating evidence suggests that niclosamide is a multifunctional drug capable of inhibiting or modulating multiple signaling pathways and biological processes, which has been demonstrated to treat endometriosis in vitro and in vivo experiments. Recent niclosamide was reported can effectively reduce the endometriosis of endometriosis lesions in mice (ELL) induced by peritoneal macrophages (LPM) and LPM the expression of related genes, and by reducing ELL and pelvic organs may stimulate the peripheral nerve as a medium of inammatory factor to reduce the abnormal inammation, may eventually reduce the pain associated[52]. In the endometriosis model in mice, chlorine nitramine can not only through targeted STAT3 and NFkB signaling pathways, reduce the growth and progress of the sample endometriosis lesions, but also can inhibit the inammatory mechanisms, thereby reducing the macrophages induced cell activity and the secretion of cytokine/chemokine based on not affect reproductive function[20–22]. At present, although niclosamide has not been used in the clinical treatment of endometriosis, the results of previous studies and our results suggest that niclosamide may be a novel strategy for the targeted treatment of inammatory dysfunction in endometriosis.

Conclusion

Four diagnostic genes related to NLRP3 activation and EMS were identied by bioinformatics. Although we have explored the biological processes and pathways involved in them, further experimental verication is needed to verify these functions. The nomogram based on these four genes has a good diagnostic effect on EMS, which provides a theoretical basis for clinical diagnosis. In addition, these diagnostic genes were found to be associated with different immune factors, suggesting that they may also have important roles in the immune microenvironment. Currently, drugs targeting these pyroptosis genes are predicted to alleviate EMS, but only niclosamide has the results of basic studies to support its use in the treatment of EMS, and further studies are needed to explore its specic mechanism of action. Firstly, the GSE7307 dataset was downloaded from the GEO database, including 18 EMS samples and 23 control samples. The nal 14 DEGs related to pyroptosis and EMS were obtained from the endometrial samples of GSE7307 by differential analysis. GO and KEGG analysis showed that these genes were mainly involved in two major biological processes. Random Forest (RF) and support vector machine recursive feature elimination (SVM-RFE) algorithms were used to select four genes to construct the EMS diagnostic model. The model was validated in endometrial samples of GSE7305 and GSE23339, and the AUC values showed that the model had a good diagnostic performance. In addition, the inltration of immune cells in the samples and the correlation between different immune factors and pyroptosis genes were further discussed. These results suggest that these diagnostic genes may also play an important role in the immunity of EMS. Finally, 10 drugs targeting these four diagnostic genes were retrieved from the DrugBank database, of which niclosamide proved useful for treating EMS. Overall, we identied four Page 13/28 key diagnostic genes for EMS. In addition, large-scale and multicenter prospective cohort studies are necessary to conrm whether these four genes also have valid diagnostic value in blood samples from EMS patients. Declarations

Acknowledgements

None. Authors’ contributions MD and PH directed the study; WN, HW and SD performed the experiments; LH, TL, LL and BW performed the data collection and statistical analysis; SZ edited the language; all the authors approved the manuscript for submission. Funding This research was supported by the National Natural Science Foundation of China (No. 81960274), the 2020 university-level Research Project of Youjiang Medical University for Nationalities (No. yy2020gcky039), and the 2021 Scientic Research and Technology Development Program of Baise City (No. 20212351). Availability of data and materials Publicly available datasets were analyzed in this study. This data can be found here: All the raw data used in this study are derived from the public GEO data portal (https://www.ncbi.nlm.nih.gov/geo/; Accession numbers: GSE7307, GSE7305 and GSE23339). Ethics approval and consent to participate All procedures were approved by the ethics review committee of Aliated Hospital of Youjiang Medical College for Nationalities.  All methods were carried out in accordance with relevant guidelines and regulations of the ethics review committee of Aliated Hospital of Youjiang Medical College for Nationalities, and informed consent was obtained from all subjects and/or their legal guardian(s). Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Page 14/28

References

1. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397:839–52. 2. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15:666–82. 3. Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25:564–91. 4. Koninckx PR, Fernandes R, Ussia A, Schindler L, Wattiez A, Al-Suwaidi S, et al. Pathogenesis Based Diagnosis and Treatment of Endometriosis. Front Endocrinol (Lausanne). 2021;12:745548. 5. Kiesel L, Sourouni M. Diagnosis of endometriosis in the 21st century. Climacteric. 2019;22:296–302. . Humphries F, Bergin R, Jackson R, Delagic N, Wang B, Yang S, et al. The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inammasome. Nat Commun. 2018;9:1560. 7. Beckerman P, Bi-Karchin J, Park ASD, Qiu C, Dummer PD, Soomro I, et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017;23:429–38. . Wang L, Hauenstein AV. The NLRP3 inammasome: Mechanism of action, role in disease and therapies. Mol Aspects Med. 2020;76:100889. 9. Zhao K, An R, Xiang Q, Li G, Wang K, Song Y, et al. Acid-sensing ion channels regulate nucleus pulposus cell inammation and pyroptosis via the NLRP3 inammasome in intervertebral disc degeneration. Cell Prolif. 2021;54:e12941. 10. Hang Y, Tan L, Chen Q, Liu Q, Jin Y. E3 ubiquitin ligase TRIM24 deciency promotes NLRP3/caspase ‐ 1/IL ‐ 1 β ‐ mediated pyroptosis in endometriosis. Cell Biology International. 2021;45:1561–70. 11. Zhou F, Zhao F, Huang Q, Lin X, Zhang S, Dai Y. NLRP3 activated macrophages promote endometrial stromal cells migration in endometriosis. Journal of Reproductive Immunology. 2022;152:103649. 12. Murakami M, Osuka S, Muraoka A, Hayashi S, Bayasula  null, Kasahara Y, et al. Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis. Reprod Biol Endocrinol. 2022;20:58. 13. Han SJ, Jung SY, Wu S-P, Hawkins SM, Park MJ, Kyo S, et al. Estrogen Receptor β Modulates Apoptosis Complexes and the Inammasome to Drive the Pathogenesis of Endometriosis. Cell. 2015;163:960–74. 14. Yu G, Wang L-G, Han Y, He Q-Y. clusterProler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7. 15. Gers FA, Schmidhuber E. LSTM recurrent networks learn simple context-free and context-sensitive languages. IEEE Trans Neural Netw. 2001;12:1333–40. 1. Huang S, Cai N, Pacheco PP, Narrandes S, Wang Y, Xu W. Applications of Support Vector Machine (SVM) Learning in Cancer Genomics. Cancer Genomics Proteomics. 2018;15:41–51. Page 15/28 17. Liang A, Huang L, Liu H, He W, Lei X, Li M, et al. Resveratrol Improves Follicular Development of PCOS Rats by Regulating the Glycolytic Pathway. Mol Nutr Food Res. 2021;e2100457. 1. Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16:385–95. 19. Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698–706. 20. Sekulovski N, Whorton AE, Shi M, MacLean JA, Hayashi K. Endometriotic inammatory microenvironment induced by macrophages can be targeted by niclosamide † . Biol Reprod. 2019;100:398–408. 21. Prather GR, MacLean JA, Shi M, Boadu DK, Paquet M, Hayashi K. Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model. Biol Reprod. 2016;95:76. 22. Sekulovski N, Whorton AE, Tanaka T, Hirota Y, Shi M, MacLean JA, et al. Niclosamide suppresses macrophage-induced inammation in endometriosis † . Biol Reprod. 2020;102:1011–9. 23. Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, et al. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res. 2014;20:6163–74. 24. Moses AS, Taratula OR, Lee H, Luo F, Grenz T, Korzun T, et al. Nanoparticle-Based Platform for Activatable Fluorescence Imaging and Photothermal Ablation of Endometriosis. Small. 2020;16:e1906936. 25. Shao B-Z, Xu Z-Q, Han B-Z, Su D-F, Liu C. NLRP3 inammasome and its inhibitors: a review. Front Pharmacol. 2015;6:262. 2. Huang Y, Li R, Hu R, Yao J, Yang Y. PEG2-Induced Pyroptosis Regulates the Expression of HMGB1 and Promotes hEM15A Migration in Endometriosis. Int J Mol Sci. 2022;23:11707. 27. Di Nicuolo F, Castellani R, De Cicco Nardone A, Barbaro G, Paciullo C, Pontecorvi A, et al. Alpha-Lipoic Acid Plays a Role in Endometriosis: New Evidence on Inammasome-Mediated Interleukin Production, Cellular Adhesion and Invasion. Molecules. 2021;26:E288. 2. Wenjing F, Tingting T, Qian Z, Hengquan W, Simin Z, Agyare OK, et al. The role of IL-1 β in aortic aneurysm. Clin Chim Acta. 2020;504:7–14. 29. He Y, Hara H, Núñez G. Mechanism and Regulation of NLRP3 Inammasome Activation. Trends Biochem Sci. 2016;41:1012–21. 30. J H, X C, Y L. HMGB1 Mediated Inammation and Autophagy Contribute to Endometriosis. Frontiers in endocrinology [Internet]. Front Endocrinol (Lausanne); 2021 [cited 2022 Oct 16];12. 31. Wang W, Li G, De Wu  null, Luo Z, Pan P, Tian M, et al. Zika virus infection induces host inammatory responses by facilitating NLRP3 inammasome assembly and interleukin-1 β secretion. Nat Commun. 2018;9:106. 32. Akoum A, Al-Akoum M, Lemay A, Maheux R, Leboeuf M. Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and Page 16/28 pelvic pain. Fertil Steril. 2008;89:1618–24. 33. Peng B, Alotaibi FT, Sediqi S, Bedaiwy MA, Yong PJ. Role of interleukin-1 β in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis. Hum Reprod. 2020;35:901–12. 34. Mita S, Shimizu Y, Sato A, Notsu T, Imada K, Kyo S. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor- α or interleukin-1 β . Fertil Steril. 2014;101:595–601. 35. Liu Y, Zhang Z, Lu X, Meng J, Qin X, Jiang J. Anti-nociceptive and anti-inammatory effects of sulforaphane on sciatic endometriosis in a rat model. Neurosci Lett. 2020;723:134858. 3. Nie K, Li J, Peng L, Zhang M, Huang W. Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer. Front Mol Biosci. 2022;9:837393. 37. Mo H-Q, Tian F-J, Ma X-L, Zhang Y-C, Zhang C-X, Zeng W-H, et al. PDIA3 regulates trophoblast apoptosis and proliferation in preeclampsia via the MDM2/p53 pathway. Reproduction. 2020;160:293–305. 3. Tu Z, Ouyang Q, Long X, Wu L, Li J, Zhu X, et al. Protein Disulde-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively. Front Immunol. 2022;13:837512. 39. Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A. 2007;104:12451–6. 40. Xiang R, Chen P, Zeng Z, Liu H, Zhou J, Zhou C, et al. Transcriptomic analysis shows that surgical treatment is likely to inuence the endometrial receptivity of patients with stage III/IV endometriosis. Front Endocrinol (Lausanne). 2022;13:932339. 41. Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090. 42. Zhong Q, Yang F, Chen X, Li J, Zhong C, Chen S. Patterns of Immune Inltration in Endometriosis and Their Relationship to r-AFS Stages. Front Genet. 2021;12:631715. 43. Je M, Sh A, Rm M, Sp M, At F, M K, et al. IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis. Frontiers in immunology [Internet]. Front Immunol; 2020 [cited 2022 Oct 19];11. 44. Laganà AS, Salmeri FM, Ban Frange ž H, Ghezzi F, Vrta č nik-Bokal E, Granese R. Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease. Gynecol Endocrinol. 2020;36:441–4. 45. Sugamata M, Ihara T, Uchiide I. Increase of activated mast cells in human endometriosis. Am J Reprod Immunol. 2005;53:120–5. 4. Guo X, Xu X, Li T, Yu Q, Wang J, Chen Y, et al. NLRP3 Inammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis. Front Immunol. 2021;12:749979. Page 17/28 47. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noël J-C. Pain, mast cells, and nerves in peritoneal, ovarian, and deep inltrating endometriosis. Fertil Steril. 2006;86:1336–43. 4. Binda MM, Donnez J, Dolmans M-M. Targeting mast cells: a new way to treat endometriosis. Expert Opin Ther Targets. 2017;21:67–75. 49. Blumenthal RD, Samoszuk M, Taylor AP, Brown G, Alisauskas R, Goldenberg DM. Degranulating eosinophils in human endometriosis. Am J Pathol. 2000;156:1581–8. 50. Eidukaite A, Tamosiunas V. Activity of eosinophils and immunoglobulin E concentration in the peritoneal uid of women with endometriosis. Clin Chem Lab Med. 2004;42:590–4. 51. Chen W, Mook RA, Premont RT, Wang J. Niclosamide: Beyond an antihelminthic drug. Cell Signal. 2018;41:89–96. 52. Shi M, Sekulovski N, Whorton AE, MacLean JA, Greaves E, Hayashi K. Ecacy of niclosamide on the intra ‐ abdominal inammatory environment in endometriosis. FASEB j [Internet]. 2021 [cited 2022 Oct 20];35. Table 1 Table 1. Predictive top 10 pharmacologic agent candidates for EMS with NLRP3 activation. Page 18/28 Drug name Padj OddsRatio CombinedScore Genes Triclocarban CTD 00000497 0.00 713.14 8021.85910 IL1B;NLRP3 chlorhexidine CTD 00005633 0.00 498.90 5271.69962 IL1B;NLRP3 uric acid CTD 00006967 0.00 498.90 5271.69962 IL1B;NLRP3 GNF-Pf-4325 BOSS 0.00 486.71 5119.715195 IL1B;NLRP3 niclosamide BOSS 0.00 464.02 4838.479209 IL1B;NLRP3 9-Methoxyellipticine TTD 00001373 0.00 464.02 4838.479209 IL1B;NLRP3 niclosamide 0.00 415.58 4245.007066 IL1B;NLRP3 chlorhexidine 0.00 415.58 4245.007066 IL1B;NLRP3 5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxideTTD 00001179 0.00 398.92 4043.246313 IL1B;NLRP3 thimerosal BOSS 0.00 332.27 3249.969098 IL1B;NLRP3   Figures Page 19/28 Figure 1 The workow of the analysis Figure 2 Page 20/28 The dysregulated genes were shown in the (A) boxplot and (B) heat map via analyzing GSE7307 datasets. 14 DEGs were identied between EMS samples and normal samples. Figure 3 (A) GO and (B) KEGG pathway analyses of 14 DEGs in EMS. Page 21/28 Figure 4 Selection procedure of diagnostic markers for EMS diagnoses.  (A) An illustration of biological marker screening through the SVM-RFE arithmetic. (B)Tuning feature selection in the random forest model. (C) Analyze the meaning of NLRP3 activation-related genes using the scores returned by the random forest model. (D) Venn graph presenting 4 diagnostic biomarkers shared by the random forest and SVM-RFE arithmetic methods. Page 22/28 Figure 5 The expression of four biomarkers in EMS and the diagnostic value of four biomarkers in GSE7307 were studied by ROC analysis. (A) NLRP3, IL-1 Β , and LY96 were highly expressed in EMS. PDIA3 was lowly expressed in EMS. (B)The diagnostic value of the 4 biomarkers was studied using ROC assays in GSE7307. Page 23/28 Figure 6

Results

of differential gene expression of NLRP3, LY96, IL-1 β and PDIA3 at the protein level between EMS and control samples. (A) Western blotting results. (B) Densitometry of the western blot. N=6 each group. *P<0.05 and **P<0.01. Page 24/28 Figure 7 ROC curve analysis of the model EMS in the validation datasets (GSE7305 and GSE23339). Page 25/28 Figure 8 Identication of NLRP3 activation-related genes. (A) Boxplots of the residuals of the sample. Red dot stands for root mean square of residuals. (B) Cumulative residual distribution map of the sample. (C) The AUC value of the ROC curve indicated that the accuracy of GLM model (0.933) was the highest among the four models. (D) The ROC curve assesses the accuracy of the four models in the validation datasets (GSE7305 and GSE23339). Page 26/28 Figure 9 GSEA revealed the enriched pathways of four biomarkers. (A)NLRP3, (B) IL-1 Β , (C) LY96, and (D)PDIA3. Page 27/28 Figure 10 Immune inltration and immune-related factors. (A)The number of immune cells in each EMS sample is represented by a different color. (B) Differences of the inltrate immune cells between the normal (blue) and EMS (red) groups. (C) Heat map of correlation of four biomarkers (NLRP3, IL-1B, LY96, and PDIA3) with 22 immune cell subsets. (D) Correlation between NLRP3, IL-1B, LY96, and PDIA3 and inltrating immune cells in EMS. Page 28/28 Figure 11 Construction and assessment of a nomogram model for EMS diagnosis based on the training set. (A) Nomogram to predict the occurrence of EMS. (B)Calibration curve to assess the predictive power of the nomogram model. (C) Decision curve analysis (DCA) to evaluate the clinical value of the nomogram model.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosischronic_pelvic_paininfertility

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-11-21T06:17:04.340742+00:00
pubmed
last seen: 2026-11-21T06:13:37.236609+00:00
unpaywall
last seen: 2026-11-05T06:08:55.941966+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine